| MYC regulates the antitumor immune response through CD47 and PD-L1 SC Casey, L Tong, Y Li, R Do, S Walz, KN Fitzgerald, AM Gouw, V Baylot, ... Science 352 (6282), 227-231, 2016 | 1190 | 2016 |
| Salmonella Typhimurium utilizes a T6SS-mediated antibacterial weapon to establish in the host gut TG Sana, N Flaugnatti, KA Lugo, LH Lam, A Jacobson, V Baylot, ... Proceedings of the National Academy of Sciences 113 (34), E5044-E5051, 2016 | 313 | 2016 |
| The MYC oncogene is a global regulator of the immune response SC Casey, V Baylot, DW Felsher Blood, The Journal of the American Society of Hematology 131 (18), 2007-2015, 2018 | 199 | 2018 |
| Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E C Andrieu, D Taieb, V Baylot, S Ettinger, P Soubeyran, A De-Thonel, ... Oncogene 29 (13), 1883-1896, 2010 | 168 | 2010 |
| OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer V Baylot, C Andrieu, M Katsogiannou, D Taieb, S Garcia, S Giusiano, ... Cell death & disease 2 (10), e221-e221, 2011 | 126 | 2011 |
| TCTP as therapeutic target in cancers J Acunzo, V Baylot, A So, P Rocchi Cancer treatment reviews 40 (6), 760-769, 2014 | 107 | 2014 |
| Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma I Lai, S Swaminathan, V Baylot, A Mosley, R Dhanasekaran, M Gabay, ... Journal for immunotherapy of cancer 6, 1-11, 2018 | 98 | 2018 |
| Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer V Baylot, M Katsogiannou, C Andrieu, D Taieb, J Acunzo, S Giusiano, ... Molecular Therapy 20 (12), 2244-2256, 2012 | 97 | 2012 |
| MYC: master regulator of immune privilege SC Casey, V Baylot, DW Felsher Trends in immunology 38 (4), 298-305, 2017 | 87 | 2017 |
| The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets M Katsogiannou, C Andrieu, V Baylot, A Baudot, NJ Dusetti, O Gayet, ... Molecular & Cellular Proteomics 13 (12), 3585-3601, 2014 | 73 | 2014 |
| Hsp27 as a therapeutic target in cancers J Acunzo, C Andrieu, V Baylot, A So, P Rocchi Current drug targets 15 (4), 423-431, 2014 | 65 | 2014 |
| Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer S Karaki, S Benizri, R Mejías, V Baylot, N Branger, T Nguyen, B Vialet, ... Journal of Controlled Release 258, 1-9, 2017 | 56 | 2017 |
| Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC) R Dhanasekaran, M Gabay-Ryan, V Baylot, I Lai, A Mosley, X Huang, ... Oncotarget 9 (5), 5517, 2018 | 46 | 2018 |
| MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity R Dhanasekaran, V Baylot, M Kim, S Kuruvilla, DI Bellovin, N Adeniji, ... Elife 9, e50731, 2020 | 42 | 2020 |
| TP53INP1 as new therapeutic target in castration‐resistant prostate cancer S Giusiano, V Baylot, C Andrieu, L Fazli, M Gleave, JL Iovanna, ... The Prostate 72 (12), 1286-1294, 2012 | 16 | 2012 |
| TCTP has a crucial role in the different stages of prostate cancer malignant progression V Baylot, S Karaki, P Rocchi TCTP/tpt1-Remodeling Signaling from Stem Cell to Disease, 255-261, 2017 | 12 | 2017 |
| Castration-resistant prostate cancer: from uncovered resistance mechanisms to current treatments TK Le, QH Duong, V Baylot, C Fargette, M Baboudjian, L Colleaux, ... Cancers 15 (20), 5047, 2023 | 6 | 2023 |
| Synthesis, Crystal Structure and Anti-Leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one J Guillon, S Savrimoutou, S Albenque-Rubio, N Pinaud, N Fillová, ... Molbank 2023 (3), M1691, 2023 | 1 | 2023 |
| MYC is the master switch between tumor dormancy and relapse in Hepatocellular carcinoma (HCC) R Dhanasekaran, V Baylot, A Mosley, D Felsher Hepatology 66, 966A-966A, 2017 | 1 | 2017 |
| Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs V Baylot, TK Le, D Taïeb, P Rocchi, L Colleaux Communications Biology 7 (1), 489, 2024 | | 2024 |
